Leadership Development to Advance Equity in Health Care
Join us for a webinar on the Leadership Development to Advance Equity in Health Care program, offered by Harvard Chan School Executive and Continuing Education.
Program Director Dr. Mary E. Fleming will share how this program equips participants to recognize, address, and dismantle health disparities. Through the program, participants will develop the leadership tools to identify and reform biased policies, foster inclusive environments, and champion health equity.
If you’re looking to advance equity in your community or practice, this webinar is a great opportunity to see how the program can support your goals.
Speaker Information
Organizers
Seeking answers in women’s health: A research agenda for the coming decade
While we understand more about women’s health than ever before, critical gaps remain. How can we delve deeper into the lifestyle and genetic factors that shape women’s risks for cancer, cardiovascular disease, and diabetes? What new insights might we uncover about brain health by examining the interplay between nutrition, exercise, and memory? How do environmental toxins and air pollution contribute to the risk of chronic illness? Join leading investigators from the landmark Nurses’ Health Study—and hear firsthand from a study participant—as they explore pressing questions and emerging frontiers in women’s health research.
Register for free to submit your questions.
An on-demand video will be posted after the event.
Speakers
Moderator
Mark Herz
About The Studio
Why Are Pathobiological Analyses and Insights Valuable in Epidemiology? A Primer for Epidemiologists
Join us on Wednesday, September 17 for the Epidemiology Seminar Series, featuring Dr. Shuji Ogino discussing Why Are Pathobiological Analyses and Insights Valuable in Epidemiology? A Primer for Epidemiologists.
Abstract: Our understanding of disease pathogenesis, which has substantially advanced, is an integral component of epidemiology. However, there exists a gap between pathobiology and epidemiology in education as well as research practice. How recent advances in pathobiological sciences can be seamlessly integrated into epidemiology has been a main theme in the field of molecular pathological epidemiology. This lecture utilizes research examples to illuminate how this integration can upgrade both epidemiology and pathobiological sciences. Furthermore, it is increasingly evident that long-term risk factor exposures play pivotal etiologic roles in many chronic diseases such as cancer. Therefore, the concept of the prospective cohort incident-tumor biobank method (PCIBM) is also illustrated with its unprecedented ability to examine long-term exposures in relation to tumor incidence plus detailed disease phenotyping.
Bio: Dr. Ogino has spearheaded to develop the integrative science of molecular pathological epidemiology (MPE). Dr. Ogino founded the International Molecular Pathological Epidemiology (MPE) Meeting Series in 2013 and has been serving as its Chair/Co-Chair for six past meetings. Leveraging the MPE approach, Dr. Ogino is a leading investigator to study the interactive roles of long-term risk factor exposures, genetics, systemic conditions, microbiome, and immunity in colorectal cancer (CRC) biology and etiologies. Based on the prospective cohort incident-tumor biobank method (PCIBM), many discoveries (“since 2007”) of the etiological links between long-term exposures and CRC incidence plus pathobiological phenotyping remain quite unique, as no other group has been able to conduct similar (replication) studies for up to 18 years. Recently, Dr. Ogino’s additional focus is research on early-onset cancers that have shown rising incidence in recent decades (e.g., those in the breast, kidney, uterus, and many digestive organs). As one of thought leaders in this particular topic, Dr. Ogino applies integrative research approaches to address this global issue. For his unique transdisciplinary scientific contribution, Dr. Ogino has received numerous awards and honors.
Speaker Information
Shuji Ogino, MD, PhD, MS
Organizers
Related Events
Health Care Quality Improvement: From Design to Implementation
Join us for a webinar on the Health Care Quality Improvement: From Design to Implementation program, offered by Harvard Chan School Executive and Continuing Education.
Program Director Dr. M. Rashad Massoud will share how this hands-on, simulation-based course guides participants through the full improvement cycle—from identifying gaps in care to designing, testing, and implementing effective solutions. You’ll learn to apply proven frameworks in health care settings and receive real-time faculty feedback.
If you’re looking to lead impactful quality improvement initiatives in your organization, this webinar is a great opportunity to see how the program can support your goals.
Speaker Information
Organizers
The Global Flourishing Study
Join us on Wednesday, December 3 for the Epidemiology Seminar Series, featuring Dr. Tyler VanderWeele discussing The Global Flourishing Study.
Abstract: The Global Flourishing Study is a longitudinal panel study of over 200,000 participants in 22 geographically and culturally diverse countries, spanning all six populated continents, with nationally representative sampling and intended annual survey data collection for 5 years to assess numerous aspects of flourishing and its possible determinants. The study is intended to expand our knowledge of the distribution and determinants of flourishing around the world. Relations between a composite flourishing index and numerous demographic characteristics are reported. Participants were also surveyed about their childhood experiences, which were analyzed to determine their associations with subsequent adult flourishing. Analyses are presented both across and within countries, and discussion is given as to how the demographic and childhood relationships vary by country and which patterns appear to be universal versus culturally specific. Brief comment is also given on the results of a whole series of papers in the Global Flourishing Study Special Collection, employing similar analyses, but with more-specific aspects of well-being. The Global Flourishing Study expands our knowledge of the distribution and determinants of well-being and provides foundational knowledge for the promotion of societal flourishing.
Bio: Tyler J. VanderWeele, Ph.D., is the John L. Loeb and Frances Lehman Loeb Professor of Epidemiology in the Departments of Epidemiology and Biostatistics at the Harvard T.H. Chan School of Public Health, and Director of the Human Flourishing Program and Co-Director of the Initiative on Health, Spirituality, and Religion at Harvard University. He holds degrees from the University of Oxford, University of Pennsylvania, and Harvard University in mathematics, philosophy, theology, finance, and biostatistics. His methodological research is focused on theory and methods for distinguishing between association and causation in the biomedical and social sciences and, more recently, on psychosocial measurement theory. His empirical research spans psychiatric and social epidemiology; the science of happiness and flourishing; and the study of religion and health. He is the recipient of the 2017 Presidents’ Award from the Committee of Presidents of Statistical Societies (COPSS).
Speaker Information
Tyler VanderWeele, PhD
Organizers
Related Events
Dementia Risk and Prevention – Lessons from the Atherosclerosis Risk in Communities Cohort
Join us on Wednesday, September 10 for the Epidemiology Seminar Series, featuring Dr. Josef Coresh discussing Dementia Risk and Prevention – Lessons from the Atherosclerosis Risk in Communities Cohort.
Abstract: Dementia is one of the leading threats to the health of our aging population. The Atherosclerosis Risk in Communities (ARIC) study contributed major insights by observing over 15,000 US adults since the late 1980s. We will discuss observations on the lifetime risk of dementia, the relationship of risk to vascular risk factors, insights into the to the biology of dementia by proteomics, brain imaging and blood brain biomarkers and their implications for prevention.
Bio: Dr. Coresh is the Founding Director of the Optimal Aging Institute and the Terry and Mel Karmazin Professor of Population Health and Medicine at NYU Grossman School of Medicine. The institute leverages epidemiologic cohorts to advance discovery, prevention and treatment of aging related diseases. Dr. Coresh continues to co-lead of the ARIC Neurocognitive Study (MPI: Coresh/Mosley. Chair: Gottesman) renewal (2023-2028) and CKD Prognosis Consortium (2023-2028; MPI: Coresh/grams) as well as start new initiatives. Dr. Coresh is an international expert in aging and vascular disease epidemiology of the brain, heart and kidney, using a range of epidemiology and data science methods. Dr. Coresh is among the most cited researcher having co-authored articles cited over 300,000 times according to Google Scholar. He received the top scientific and patient impact awards of the US National Kidney Foundation (Eknoyan and Hume awards) and American Society of Nephrology (Belding Scribner award). His devotion to mentorship was recognized by awards from Johns Hopkins University and the American Heart Association.
Speaker Information
Josef Coresh, MD, PhD
Organizers
Related Events
Excess Deaths: History of a Contested Concept
Join us on Wednesday, September 3 for the Epidemiology Seminar Series, featuring Dr. David Jones discussing Excess Deaths: History of a Contested Concept.
Abstract: The measure of “excess deaths” has become a familiar and important concept in epidemiology and health statistics, especially during crises when direct counts of mortality are complicated (e.g., COVID-19, heat waves and other natural disasters, etc.). While the measure is useful, and can be politically powerful, it is also problematic: methodological compromises inevitably expose the reported counts to contestation that often seeks to deny the seriousness of the health threat. I will explore the history of the concept of “excess deaths,” describing the challenges it hoped to solve, some of the competing measures (e.g., expected deaths), and the persistent debates. By understanding the history of the concept and the debates, it is possible to develop strategies for using the concept most effectively.
Bio: Trained in psychiatry and history of science, David Jones teaches history of medicine, medical ethics, and social medicine at Harvard University. His research has ranged from the history of epidemics to heart disease, cardiac therapeutics, race, air pollution, and the health effects of the climate crisis.
Speaker Information
David S. Jones, MD, PhD
Organizers
Related Events
As birth rates decline in the U.S., policymakers are debating whether to encourage a baby boom—and if so, how. Ideas range from funding bank accounts for newborns to lowering the cost of in vitro fertilization to changing tax policy to encourage larger families. This panel brings together health and policy experts to explore the drivers of declining fertility, consider whether the U.S. needs more births, and discuss innovative strategies to improve the health of moms and babies.
Moderator
Veronica Adamson
About The Studio
Smart Solutions, Hidden Costs: Weighing AI’s Climate and Health Impact
The Department of Environmental Health and the Harvard Chan Center for Climate, Health, and the Global Environment (C-CHANGE) hosted this live webinar as part of Harvard Climate Action Week.
Smart Solutions, Hidden Costs: Weighing AI’s Climate and Health Impact
The AI boom introduces new possibilities for identifying and implementing innovative climate solutions that can protect communities and improve health. At the same time, the water and energy resources — and resulting fossil fuel emissions — needed to cool and power AI’s data centers create new and growing threats to health. In this webinar, Harvard experts will address AI’s complex relationship with both climate and health outcomes, acknowledging both the transformative potential and the real costs involved.
Speaker Information
Organizers
Dana-Farber/Harvard Cancer Center Celebration of Early Career Investigators in Cancer Research
Early career investigators are a unique reservoir of new ideas, innovation, and excellence in cancer research. To celebrate this, we welcome you to join the Annual DF/HCC Celebration of Early Investigators in Cancer Research. This symposium will showcase the talent of early career investigators at the Dana-Farber/Harvard Cancer Center (DF/HCC) who work in several areas of population science, including epidemiology, biostatistics, outcomes, diversity, and survivorship. We invite all members of the public to attend the event. We also invite students, post-docs, residents, and clinical fellows to submit abstracts for consideration as oral or poster presentations. We look forward to an exciting afternoon of discussion, sharing new discoveries, and building new collaborations.